Pentraxin Therapeutics Overview
- Founded
- 2001
- Status
- Private
- Latest Deal Type
- Grant
- Latest Deal Amount
- $7M
- Investors
- 4
Pentraxin Therapeutics General Information
Description
Developer of drugs research platform intended to offer treatment of amyloidosis and amyloid-related diseases. The company's platform designs and develops new treatments for systemic amyloidosis and amyloid-related diseases, Alzheimer's disease and type II diabetes and targeting the pathogenic effects of C-reactive protein in cardiovascular and inflammatory diseases, enabling doctors to cure amyloid-related diseases and to speed up patients' access to new medicines.
Contact Information
Website
Formerly Known As
Hallco 646
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- C/O UCL Business PLC The Network Building
- 97 Tottenham Court Road
- London W1T 4TP
- England, United Kingdom
Pentraxin Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 29-Sep-2008 | $7M | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Startup |
Pentraxin Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Pepys Ph.D | Founder, Head of Medicine & Director |
Pentraxin Therapeutics Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Cengiz Tarhan | UCL Business | Director | 000 0000 |
| Mark Pepys Ph.D | Pentraxin Therapeutics | Founder, Head of Medicine & Director | 000 0000 |
| Philip Hawkins Ph.D | Pentraxin Therapeutics | Director | 000 0000 |
| Stephen Wood | Pentraxin Therapeutics | Director | 000 0000 |
Pentraxin Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Wellcome Trust | Limited Partner | 000 0000 | 000000 0 | ||
| Philip Hawkins | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Stephen Wood | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| UCL Business | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |